[go: up one dir, main page]

SI1811987T1 - Suh prah, ki obsega levotiroksin natrij, ki ga dajemo preko inhalatorja - Google Patents

Suh prah, ki obsega levotiroksin natrij, ki ga dajemo preko inhalatorja

Info

Publication number
SI1811987T1
SI1811987T1 SI200430756T SI200430756T SI1811987T1 SI 1811987 T1 SI1811987 T1 SI 1811987T1 SI 200430756 T SI200430756 T SI 200430756T SI 200430756 T SI200430756 T SI 200430756T SI 1811987 T1 SI1811987 T1 SI 1811987T1
Authority
SI
Slovenia
Prior art keywords
dry powder
inhalator
levothyroxine sodium
administered via
sodium administered
Prior art date
Application number
SI200430756T
Other languages
English (en)
Inventor
Ioulia Tseti
Original Assignee
Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa filed Critical Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa
Publication of SI1811987T1 publication Critical patent/SI1811987T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200430756T 2004-11-18 2004-11-18 Suh prah, ki obsega levotiroksin natrij, ki ga dajemo preko inhalatorja SI1811987T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04798720A EP1811987B1 (en) 2004-11-18 2004-11-18 Dry powder comprising levothyroxine sodium administered via inhalator
PCT/GR2004/000055 WO2006054120A1 (en) 2004-11-18 2004-11-18 Dry powder comprising levothyroxine sodium administered via inhalator

Publications (1)

Publication Number Publication Date
SI1811987T1 true SI1811987T1 (sl) 2008-08-31

Family

ID=34959179

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430756T SI1811987T1 (sl) 2004-11-18 2004-11-18 Suh prah, ki obsega levotiroksin natrij, ki ga dajemo preko inhalatorja

Country Status (13)

Country Link
US (1) US8333192B2 (sl)
EP (1) EP1811987B1 (sl)
AT (1) ATE390919T1 (sl)
CY (1) CY1107972T1 (sl)
DE (1) DE602004012904T2 (sl)
DK (1) DK1811987T3 (sl)
ES (1) ES2304631T3 (sl)
HR (1) HRP20080261T3 (sl)
PL (1) PL1811987T3 (sl)
PT (1) PT1811987E (sl)
RS (1) RS50582B (sl)
SI (1) SI1811987T1 (sl)
WO (1) WO2006054120A1 (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016218604A1 (de) * 2016-09-27 2018-03-29 Constantin Adams Partikuläres Stoffgemisch, vorzugsweise zur Verwendung bei der Prophylaxe und/oder Behandlung einer Atemwegsstörung
WO2018069805A2 (en) 2016-10-10 2018-04-19 Ftf Pharma Private Limited Method for preparation of liquid oral composition of l-thyroxin
EP3644983B1 (en) 2017-06-29 2023-10-25 Yale University Compositions and methods of treating or preventing fibrotic lung diseases
JP2021521280A (ja) 2018-04-12 2021-08-26 マトルクス セラピューティクス コーポレーション 弾性線維分解を治療するための組成物及び方法
WO2019201712A1 (en) 2018-04-16 2019-10-24 Ioulia Tseti A pharmaceutical dry powder composition for inhalation comprising a thyroid hormone

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE461013B (sv) * 1988-02-11 1989-12-18 Christian Wesslau Farmaceutisk komposition verksam mot lungobstruktioner bestaaende av en betaadrenerg antagonist och ett tyroideahormon
JP3084059B2 (ja) 1990-02-05 2000-09-04 ビーティージー・インターナショナル・インコーポレーテッド 甲状腺ホルモン心臓治療
US5161524A (en) 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
DE19821625C1 (de) 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
GB9827200D0 (en) 1998-12-11 1999-02-03 Glaxo Group Ltd Dry powder inhaler
US6645526B2 (en) 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
GR1004350B (el) 2002-03-29 2003-09-26 Συσκευη εισπνοων ξηρης σκονης

Also Published As

Publication number Publication date
US8333192B2 (en) 2012-12-18
PT1811987E (pt) 2008-05-26
US20080178870A1 (en) 2008-07-31
HRP20080261T3 (en) 2008-09-30
ATE390919T1 (de) 2008-04-15
ES2304631T3 (es) 2008-10-16
EP1811987A1 (en) 2007-08-01
PL1811987T3 (pl) 2008-08-29
DE602004012904T2 (de) 2009-04-16
DE602004012904D1 (de) 2008-05-15
EP1811987B1 (en) 2008-04-02
WO2006054120A1 (en) 2006-05-26
DK1811987T3 (da) 2008-07-14
RS50582B (sr) 2010-05-07
CY1107972T1 (el) 2013-09-04

Similar Documents

Publication Publication Date Title
HRP20080261T3 (en) Dry powder comprising levothyroxine sodium administered via inhalator
TW200633730A (en) Oral disintegrating dosage forms
EG24327A (en) Powder inhaler
MY153151A (en) Inhalation kit comprising inhalable powder of tiotropium
IS7142A (is) Lyfjasamsetningar, sem innihalda morfíngerandaefni, ásamt losanlegu en hömdu mótlyfi
MX2008012731A (es) Tabletas de paracetamol de liberacion rapida.
DE602005024241D1 (de) Inhalator für pulverförmige zubereitungen
MY125766A (en) Flash-melt oral dosage formulation
EP3895698A3 (en) Pharmaceutical compositions comprising iron oxy-hydroxide
GEP20063905B (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
PL1603615T3 (pl) Ulepszony układ inhalatora suchego proszku
AU2003275357A1 (en) Analgesic compositions comprising nmda receptor antagonists and benzalkonium chloride
TR201910393T4 (tr) Bir inhalatör için ağızlık.
PH12012501150A1 (en) Nutritional compositions and methods for optimizing dietary acid-base potential
MY152647A (en) Powder inhaler
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
NZ594669A (en) Oral composition of Vorinostat
PL374827A1 (en) Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation
WO2003061557A3 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
WO2003013441A3 (en) Levothyroxine compositions and methods
WO2004014318A3 (en) Levothyroxine compositions and methods
PL1586320T3 (pl) Stała postać dawkowania zawierająca cytyzynę
MX2009003772A (es) Formulaciones de oximorfona robustas, de liberacion sostenida.
EP1416918A4 (en) SYNERGISTIC FILLING COMPOSITION